NYAX enters the back half of August in freefall, with a brutal earnings reaction driving a 23% weekly collapse and the ORTEX short score climbing to its highest reading in the past two weeks.
The catalyst was unambiguous. Nayax's earnings announcement on August 10 triggered a single-day loss of nearly 25%, the kind of move that rewires how the market thinks about a stock's fair value. The P/E multiple compressed sharply in response — falling more than 11 points over the week to 39.3, and the EV/EBITDA ratio shed 3.6 turns to 18.1. Even after that reset, valuation is not obviously cheap: an EV/EBIT score in the 3rd percentile signals the stock remains expensive relative to its universe on earnings-based metrics, while forward EPS estimates rank in the 90th percentile for year-on-year growth — a split that captures the central tension, a fast-growing business whose price still demands near-perfection.
The short-side setup is less aggressive than the price action might imply. Short interest sits well below the threshold where a squeeze narrative takes hold, and borrow conditions are genuinely loose — availability runs at 353%, meaning roughly three-and-a-half shares are available to borrow for every one already out on loan, the highest it has been in the past 30 days after tightening modestly this week. Cost to borrow has drifted down about 7% on the week to just over 4%, near the low end of the range it has held since July. The ORTEX short score climbed from 36 to 44 over the past week — a meaningful step up — though at the 35th percentile for its sector, the reading reflects growing but still-moderate short-side conviction rather than crowded positioning.
Ownership concentration adds a layer of complexity. Three founders and senior insiders — Yair Nechmad, David Ben Avi, and Amir Nechmad — collectively control roughly 57% of shares, creating a tightly held float. Below them, Meitav Investment House added over 1.7 million shares in its most recent filing through August 7, making it the largest institutional buyer in recent reporting periods. That institutional accumulation sits alongside a run of small executive sells — the CFO, Chief Strategy Officer, Chief Marketing Officer, and others all recorded sales in late June and early July — though each transaction was tiny relative to the overall cap table, and trade significance scores were uniformly low. The net insider position over 90 days is marginally positive in share count, but the direction of executive selling into what was then a rising price is worth noting in hindsight.
Analyst data on file is from 2022 and carries no weight on current valuation debates — it is omitted accordingly. Among TASE-listed peers, ACCL fell 6.9% on the week and RPOL dropped 11.4%, suggesting some sector-level pressure in Israeli electronic equipment names. Neither, however, came close to the severity of Nayax's move, which appears specific to the earnings release rather than a broad tape story.
The question shaping the next several weeks is whether the post-earnings multiple reset proves sufficient to attract fresh buyers, or whether the forward-growth premium the stock has historically commanded needs further compression before institutional flows stabilise.
See the live data behind this article on ORTEX.
Open NYAX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
